The global cardiogenic shock treatment market is poised for significant growth in the coming decade, with the market expected to reach a value of USD 1.77 Billion by 2033, up from USD 0.9 Billion in 2023. This represents a strong compound annual growth rate (CAGR) of 7% during the forecast period from 2023 to 2033.
One of the key drivers of market growth is the increasing incidence of heart disease worldwide. According to the World Health Organization, cardiovascular disease is the leading cause of death globally, accounting for 31% of all deaths. The growing prevalence of heart disease is contributing to a rising demand for effective treatment options for cardiogenic shock.
Another factor driving market growth is the increasing adoption of mechanical support devices such as Impella, ECMO, and IABPs. These devices provide mechanical support to the heart and help to restore blood flow and oxygen to the body’s organs. They have been shown to significantly improve survival rates and outcomes for patients with cardiogenic shock.
In addition to mechanical support devices, there are also several other medical devices and therapies that are being developed and tested for the treatment of cardiogenic shock, including extracorporeal carbon dioxide removal (ECCO2R) devices, microaxial flow pumps, and novel ventricular assist devices (VADs). These technologies have the potential to further improve outcomes for patients with cardiogenic shock and are expected to drive growth in the market.
Key Takeaways from the Market Study:
- From 2018 to 2022, the Cardiogenic Shock Therapies market increased at a CAGR of 3.5%.
- From 2023 to 2033, the market for cardiogenic shock treatments is projected to expand at a 7% CAGR.
- The market for treatments for cardiogenic shock is anticipated to reach USD 1.77 billion by 2033.
- The hospital sector holds the biggest market share, per the FMI research.
- For Cardiogenic Shock Therapies, North America is predicted to have a 40% market share.
- With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.
“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Cardiogenic Shock Treatments.” says an FMI analyst
Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!
Market Competition:
Key players in the market include companies such as Getinge AB, Par Pharmaceutical, Abbott, Viatris Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Terumo Corporation, Medtronic, AbioMed, Astrazeneca along with healthcare providers and technology companies among other global players.
- In October 2022, the American Heart Association established the Cardiogenic Shock Registry, powered by Get With The Guidelines®, to provide a foundation for researchers, clinicians, and regulators to better understand the clinical symptoms, treatment patterns, and outcomes of different types of shock. The registry builds on over two decades of experience with the Get With The Guidelines® platform and will inform the medical community on how to best treat cardiogenic shock. The steering committee of the registry includes experts from leading academic surgeons and cardiologists, as well as representatives from the U.S. Food & Drug Administration and the U.S. Centers for Medicare & Medicaid Services, who provide guidance on establishing and managing the data in the registry.
Key Segments Profiled in the Cardiogenic Shock Treatment Industry Survey:
Treatment Type:
- In-Vitro Test Kits
- Drugs
- Devices
End- User:
- Cardiac Catheterization Labs
- Hospitals
- Ambulatory Surgical Centres
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube